Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-01-17
1980-05-27
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 12, 23230B, G01N 3316, A61K 4300
Patent
active
042050570
ABSTRACT:
The isolation and use of cerebrospinal fluid myelin encephalitogenic protein (EP) fragments as an indicator of disease activity in multiple sclerosis is disclosed. With the use of a double-antibody radioimmunoassay, it was determined that a portion of EP cross-reacting with residues 43-88 (EP-Pl) appears in the cerebrospinal fluid during periods of exacerbation.
REFERENCES:
Fritz et al., Fed. Proc., vol. 36, No. 3, Mar. 1, 1977, p. 1297.
Government of the United States
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Cerebrospinal fluid protein fragments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cerebrospinal fluid protein fragments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cerebrospinal fluid protein fragments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1119688